Key Takeaways
Trip.com Group Limited's (NASDAQ: TCOM) stock plunged over 17 percent after a report revealed the company is under investigation by Chinese regulators for alleged monopolistic business practices.
According to complaints filed by multiple law firms, including Rosen Law Firm and The Schall Law Firm, executives made materially false and misleading statements and failed to disclose the significant regulatory risks the company faced in China.
The lawsuits center on a January 14, 2026, Bloomberg report that China's State Administration for Market Regulation (SAMR) was investigating Trip.com for antitrust conduct. The report also revealed the regulator had summoned the company in September 2025 regarding "unfair restrictions" on merchants. On this news, Trip.com's American depositary shares fell $12.90, or 17.05 percent, to close at $62.78.
The class action alleges that throughout the Class Period of April 30, 2024, to January 13, 2026, Trip.com failed to inform investors about its monopolistic activities and the associated regulatory scrutiny. This omission, the suits claim, caused the company's securities to trade at artificially inflated prices, leading to significant investor losses when the information was made public. Several law firms are now seeking to represent investors, with a May 11, 2026 deadline to file for lead plaintiff status.
The investigation into Trip.com is part of a broader trend of increased regulatory oversight of technology companies by the Chinese government, which has also impacted firms like Alibaba Group Holding Ltd. and Tencent Holdings Ltd.
The stock's sharp decline to $62.78 per share highlights the financial consequences of perceived regulatory risk in China. Investors will now watch for the court's decision on the lead plaintiff by the May 11, 2026 deadline, which will determine the future direction of the litigation.
This article is for informational purposes only and does not constitute investment advice.
